IMPLANT SITE ULCER

IMPLANT SITE ULCER was reported 29 times

IMPLANT SITE ULCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 gamma-Aminobutyric Acid-ergic Agonist [EPC] 8 0.0001
1 Progestin [EPC] 8 0.0000
2 Ester Local Anesthetic [EPC] 1 0.0000
3 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
4 Non-Standardized Chemical Allergen [EPC] 1 0.0000
5 Amide Local Anesthetic [EPC] 1 0.0000
6 Nitrate Vasodilator [EPC] 1 0.0000
7 Purine Antimetabolite [EPC] 1 0.0000
8 Antiarrhythmic [EPC] 1 0.0000
9 Alkylating Drug [EPC] 2 0.0000
10 Opioid Agonist [EPC] 1 0.0000
11 Proton Pump Inhibitor [EPC] 1 0.0000
12 Corticosteroid [EPC] 2 0.0000
13 Tumor Necrosis Factor Blocker [EPC] 1 0.0000